EP3930715
SARACATINIB FOR USE IN THE TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
26.2.2020EP published:
8.5.2024EP application number:
20710607.1
EPO information:
European Patent Register
Max expiry date:
25.2.2040
Title in English:
SARACATINIB FOR USE IN THE TREATMENT OF IDIOPATHIC PULMONARY FIBROSISLanguage of the patent:
English
Timeline
Today
26.2.2020EP application
8.5.2024EP Publication
Owner
Name:
Astrazeneca ABAddress:
151 85 Södertälje, SE
Name:
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.Address:
Hansastr. 27c, 80686 München, DE
Inventor
Name:
COUSENS, LeslieAddress:
Waltham, Massachusetts 02451, US
Name:
NIVENS, ChadAddress:
Waltham, Massachusetts 02451, US
Name:
ESCOTT, Katherine JaneAddress:
Cambridge CB2 0AA, GB
Name:
MONKLEY, SusanAddress:
Mölndal, SE
Name:
PRASSE, AntjeAddress:
München, DE
Priority
Number:
201962811009 PDate:
27.2.2019Country:
US
Classification
Categories:
A61K 31/4412, A61K 31/496, A61K 45/06, A61P 11/00